Table 1

Patient characteristics (n = 336)

Age at diagnosis, years, median (IQR)

62 (24-90)


Overall survival, months, median (IQR)

19.5 (0-271)


FIGO Stage

n (%)


1

84 (25.0)


2

36 (10.7)


3

166 (49.4)


4

40 (11.9)


Missing

10 (3.0)



Grade

n (%)


G1

39 (11.6)


G2

73 (21.7)


G3

221 (65.8)


Missing

3 (0.9)



Residual disease

n (%)


No macroscopic disease (Optimal debulking)

128 (38.1)


Macroscopic disease left

194 (57.7)


Missing

14 (4.2)



Histological type

n (%)


Serous

178 (53)


Mucinous

35 (10.4)


Endometriod

42 (12.5)


Clear cell

25 (7.4)


Undifferentiated

54 (16.1)


Missing

2 (0.6)



Chemotherapy

n (%)


Yes

236 (70.2)


No

92 (27.4)


Missing

8 (2.4)



Eag staining

n (%)


Low/Intermediate

196 (58.3)


High

53 (15.8)


Missing

87 (25.9)



HERG staining

n (%)


Low/Intermediate

181 (53.9)


High

68 (20.2)


Missing

87 (25.9)


Asher et al. Diagnostic Pathology 2010 5:78   doi:10.1186/1746-1596-5-78

Open Data